Arkolith/Insider Trading/OPRX/Form 4

Greco Theresa

Chief Commercial OfficerOptimizeRx Corp (OPRX) · full profile →Form 4 · filed May 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2025Grant(A)2K—$053K
May 15, 2025Grant(A)7K—$060K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 15, 2025Grant(A)12K—$012K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-25-026500) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML